Global

‡ In these countries please contact our distributor

IV3000*Neufield N. abstract

Smith & Nephew logo
IV3000 product logo and descriptor

Neufeld N. A randomised, controlled trial of the effectiveness of Opsite* Wound vs IV3000 in maintaining an occlusive central line fixation. McMaster University, Canada, 1991.

 

With an increasing number of elderly clients now being accepted onto our haemodialysis programme, Permcath™ (Quinton Instrument Co., Seattle, WA, USA) catheters have become the chosen form of long term vascular access in many of these people. With this has come the need not only to adapt, but where necessary change the previous format of covering dressings at the exit site of these catheters.

 

Patients who are in hospital often require frequent procedures that cause discomfort and immobilization. If we are able to reduce patient discomfort by using a more effective central line dressing the patient benefits are also seen.